Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
8.58
-0.28 (-3.16%)
Nov 20, 2024, 4:00 PM EST - Market closed
Actuate Therapeutics Statistics
Total Valuation
ACTU has a market cap or net worth of $167.58 million. The enterprise value is $154.06 million.
Market Cap | 167.58M |
Enterprise Value | 154.06M |
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
Earnings Date | Nov 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ACTU has 19.53 million shares outstanding. The number of shares has increased by 218.96% in one year.
Current Share Class | 19.53M |
Shares Outstanding | 19.53M |
Shares Change (YoY) | +218.96% |
Shares Change (QoQ) | +588.01% |
Owned by Insiders (%) | 15.14% |
Owned by Institutions (%) | 4.91% |
Float | 6.60M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 31.27 |
P/TBV Ratio | 31.27 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.68
Current Ratio | 1.68 |
Quick Ratio | 1.59 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -1,401.67 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$5.69M |
Employee Count | 5 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 7.88 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 52.21 |
Average Volume (20 Days) | 60,354 |
Short Selling Information
The latest short interest is 20,250, so 0.10% of the outstanding shares have been sold short.
Short Interest | 20,250 |
Short Previous Month | 34,113 |
Short % of Shares Out | 0.10% |
Short % of Float | 0.31% |
Short Ratio (days to cover) | 0.06 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -26.22M |
Pretax Income | -27.77M |
Net Income | -28.45M |
EBITDA | n/a |
EBIT | -26.22M |
Earnings Per Share (EPS) | -$7.37 |
Balance Sheet
Cash & Cash Equivalents | 13.52M |
Total Debt | n/a |
Net Cash | 13.52M |
Net Cash Per Share | $0.69 |
Equity (Book Value) | 5.36M |
Book Value Per Share | 0.27 |
Working Capital | 5.77M |
Cash Flow
Operating Cash Flow | -22.58M |
Capital Expenditures | n/a |
Free Cash Flow | -22.58M |
FCF Per Share | -$1.16 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ACTU does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -218.96% |
Shareholder Yield | -218.96% |
Earnings Yield | -16.98% |
FCF Yield | -13.48% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |